Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic Cancer [Phase 1]
This trial update reports the completion of a Phase 1 study evaluating the safety and tolerability of a PARP inhibitor in combination with g…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery [Phase 2]
Phase 2 clinical trial update evaluating internal Y-90 microspheres with external radiation therapy (Tomotherapy) and fluorouracil for patie…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer [Phase 3]
Phase 3 clinical trial comparing two chemotherapy regimens with observation in patients who have undergone complete surgical resection for p…
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles [Phase 2]
Phase 2 trial evaluating enoxaparin thromboprophylaxis in cancer patients with elevated tissue factor-bearing microparticles has completed w…
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: Studying Biomarkers in Patients With Pancreatic Cancer
The trial update reports the completion of a biomarker study in patients with pancreatic cancer conducted by Vanderbilt-Ingram Cancer Center…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas [Phase 3]
A Phase III study comparing ABI-007 (albumin-bound paclitaxel) plus gemcitabine versus gemcitabine alone in metastatic pancreatic cancer has…
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer [Phase 1]
Phase 1 trial evaluating ipilimumab with or without vaccine therapy in locally advanced, unresectable, or metastatic pancreatic cancer; stud…
-
CLINICAL_TRIALS trial_result · 2013-12-05Clinical Trial Update: Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update for saracatinib in previously treated metastatic pancreatic cancer has completed with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-12-05Clinical Trial Update: S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery [Phase 1, Phase 2]
Phase 1/2 trial evaluating gemcitabine and erlotinib with or without monoclonal antibody therapy in metastatic pancreatic cancer that is unr…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas [Phase 3]
A Phase 3 trial evaluating Nitrocamptothecin versus other chemotherapy in pancreatic cancer; the update provides no trial results.
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer [Phase 3]
Phase 3 trial testing nitrocamptothecin versus fluorouracil in patients with recurrent or refractory pancreatic cancer. Current status is UN…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas [NA]
This update covers a trial investigating fluorouracil and gemcitabine with external-beam radiation, with or without phosphorus-32 brachyther…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating the combination of gemcitabine hydrochloride and tanespimycin in stage IV pancreatic cancer has completed, with r…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery [Phase 2]
Phase 2 trial evaluating bevacizumab or cetuximab in combination with gemcitabine hydrochloride, capecitabine, and radiation therapy for pan…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Bevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With Gemcitabine [Phase 2]
Phase 2 clinical trial evaluating bevacizumab and erlotinib in metastatic pancreatic cancer after gemcitabine failure; results posted after …
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab and gemcitabine with either cetuximab or erlotinib in advanced pancreatic cancer has completed and post…
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas [Phase 3]
A Phase 3 clinical trial evaluating fluorouracil and gemcitabine with radiation therapy for pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-15Clinical Trial Update: Abraxane Therapy in Patients With Pancreatic Cancer Who Failed First-Line Gemcitabine Therapy [Phase 2]
Phase 2 trial of Abraxane (paclitaxel protein-bound) in patients with pancreatic cancer after failure of first-line gemcitabine; the study c…
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating radiation therapy plus paclitaxel in nonmetastatic, unresectable pancreatic cancer has completed. The study was con…
-
CLINICAL_TRIALS trial_result · 2013-10-21Clinical Trial Update: Intraoperative Cell Saver Autotransfusion Use for Major Surgical Oncology Operations.
This is a completed clinical trial update evaluating intraoperative cell saver autotransfusion during major surgical oncology operations. Th…
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas [Phase 2]
This entry notes the completion of a Phase 2 trial evaluating Triapine as first- or second-line therapy for locally advanced or metastatic p…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer [Phase 1]
Phase 1 trial of RO4929097 before surgery in pancreatic cancer was terminated. The study was sponsored by the National Cancer Institute.
-
CLINICAL_TRIALS trial_result · 2013-09-26Clinical Trial Update: Study of GSK1120212 Plus Gemcitabine vs Placebo Plus Gemcitabine in Metastatic Pancreatic Cancer [Phase 2]
This Phase 2 trial evaluated trametinib (GSK1120212) plus gemcitabine versus placebo plus gemcitabine in metastatic pancreatic cancer. The s…
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: Pilot Safety Trial of Chemotherapy and Use of Heparin in Patients With Pancreatic Cancer [Phase 1, Phase 2]
This document reports the completion of a Phase 1/2 pilot safety trial evaluating chemotherapy with the use of heparin in pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine [Phase 2]
A completed Phase 2 clinical trial evaluated arsenic trioxide in pancreatic cancer patients who were resistant to gemcitabine.